International Myeloma Foundation
MYELOMA MINUTE | Up To The Minute News | 6.2.2022
medical research scientist
imwg conf series with speaker headshots
Register Now: IMWG Conference Series 2022 Making Sense of Treatment
At the upcoming IMWG Conference Series, “Making Sense of Treatment” on Thursday, June 16, 2 p.m. ET (US and Canada), leading myeloma experts will discuss the latest drug therapy news from the June 2022 American Society of Clinical Oncology (ASCO) Annual Conference, IMF IMWG Summit, and the European Hematology Association (EHA) Annual Conference. Moderated by IMF Chairman of the Board Dr. Brian G.M. Durie, panelists will include Drs. Vincent Rajkumar (Mayo Clinic—Rochester, MN) and María V. Mateos (University of Salamanca—Salamanca, Spain).
register button
Now Open for Applications: The 2023 Brian D. Novis Research Grants
The Brian D. Novis Research Grant was established in 1995 to honor IMF co-founder Brian D. Novis, who succumbed to multiple myeloma in July 1992. The grants are awarded to researchers working in the field of multiple myeloma and related disorders, including smoldering multiple myeloma (SMM), monoclonal gammopathy of undetermined significance (MGUS), and immunoglobulin-derived amyloidosis. The 2023 grants will support senior research projects with $80,000 each and junior research projects with $50,000 each. Deadline for submission of applications is on September 1, 2022.
amazon smile for fathers day
Shop AmazonSmile for Father's Day and Give to the IMF!
When you shop at and designate the International Myeloma Foundation (IMF) as your preferred charity, Amazon donates 0.5% of all purchases you make to the IMF, at no added cost to you. Make this Father’s Day special by shopping at AmazonSmile while giving to the IMF at the same time!
Prof Jesus San Miguel headshot for Las Voces Meeting
Las Voces De Mieloma Support Group (Spanish-Virtual Meeting) on June 21
Las Voces de Mieloma Support Group will hold its Spanish virtual meeting on June 21, Tuesday from 10:00 a.m. 11:00 a.m. (Pacific Standard Time). Guest speaker will be Prof. Jesús San Miguel who is currently Director of Clinical and Translational Medicine at the University of Navarra and Medical Director of the Clínica Universidad de Navarra. Previously, he was Professor of Medicine at the University of Salamanca, Head of the Hematology Service of the University Hospital (22 years) and President of the International Myeloma Society. He has been Associate Editor of Blood and Hematologica and member of the advisory committees of the European Hematology Association, the Leukemia Research Foundation, the International Myeloma Foundation and the Multiple Myeloma Research Foundation. He has received numerous awards, including the recent Gregorio Marañón National Research Award for the area of Medicine 2021, previously the "KNAW Bob Pinedo Cancer Care Award 2020" awarded by the Royal Netherlands Academy of Arts and Sciences and the Bob Pinedo Cancer Care Foundation, the International Waldenström Award, Kyle Life Achievement Award, Jose Carreras Award, Ham-Wasserman Lecture Award, Celgene Life Achievement Career Award, EBMT Lecture Award, Michaeli Award and the King Jaime I Award for Medical Research. His scientific production translates into more than 880 international publications. To join the meeting, please register at: Once registered, you will receive an email with meeting log in information.
register button
czerkies golf outing
This Week: The 14th Annual Czerkies Memorial Golf Outing
The 14th Annual Czerkies Memorial Golf Outing will be held this Saturday, June 4, 2022, at Bolingbrook Golf Club in Bolingbrook, IL. Shotgun starts at 12:30 p.m. and will be limited to 144 golfers. For more information or to register as a golfer, volunteer, or sponsor, please email Craig Czerkies at or call (630) 721-0557.
register button
ask dr durie video about bone therapy
#ASKDRDURIE | Dr. Durie's Weekly Web Video Series
Should myeloma patients start bone therapy if they are in remission?
Watch Now
Online Patient Forum

Smart Patients: Join the Conversation
Clinical Trial Fact Sheets

CANOVA Trial (Accruing)

Phase II Relapsed or Refractory Venetoclax Trial (Accruing)

Phase I/II Trial Using a Venetoclax Combination With or Without Bortezomib (Accruing)

IKEMA Trial (Fully Accrued)

IMROZ Trial (Fully Accrued)

BOSTON Trial (Fully Accrued)
Upcoming Events

Learn More
Grand Tour of Scotland Whisky Tasting

Donate Now
Laughs 4 Life Returns

Donate Now
George and Julia’s 50th Anniversary
Webinar Replays
Watch the Replay
IMF Patient & Family Webinar — New Frontiers in Myeloma Care 

Watch the Replay
Regional Community Workshop — Midwest

Watch the Replay
Regional Community Workshop — West South Central

See also, all of our events.

We Thank Our Sponsors:

Bristol Myers Squibb, GSK, Janssen Oncology, Karyopharm Therapeutics, and Legend Biotech
We also thank individuals like you for your continued support!
Subscribe Button@2x.jpg
Join the conversation at The International Myeloma Foundation
Facebook Facebook: /Myeloma  |  Twitter Twitter @IMFMyeloma  |  Instagram Instagram @IMFmyeloma
This email was sent by:
The International Myeloma Foundation
4400 Coldwater Canyon Ave., Suite 300
Studio City, CA 91604
Connect with the IMF InfoLine
We respect your privacy and your preferences for communications of this nature.
Home  •  Unsubscribe  •  Privacy Policy
View as web page